Zobrazeno 1 - 10
of 15
pro vyhledávání: '"R. H. Jacobs"'
Autor:
Gini F. Fleming, Cathy Eng, Jacob Rotmensch, R. H. Jacobs, D. Bertucci, Ann M. Mauer, Mark J. Ratain
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(12)
Summary Background: The combination of doxorubicin, paclitaxel, and cisplatin has activity in gynecologic malignancies but requires colony stimulating factor (G-CSF) support. Moreover, there is concern about cardiotoxicity with doxorubicin/paclitaxel
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 9
Increased incidence of cardiovascular morbidity and mortality has been observed in continuous ambulatory peritoneal dialysis (CAPD) patients. Hyperlipemia is an important etiologic factor in the pathogenesis of coronary artery disease. Lovastatin has
Autor:
R H, Jacobs
Publikováno v:
Journal of Women & Aging. 5:227-227
Publikováno v:
Cancer. 56(6)
Among 172 patients with hairy cell leukemia (HCL) seen at the University of Chicago over a 10-year period, 15 were found to have a second malignancy. Neoplasia of the skin was noted most frequently; there were three cases of basal cell carcinoma, one
Autor:
R H, Jacobs
Publikováno v:
Journal of geriatric psychiatry. 15(2)
Autor:
R H, Jacobs, A, Awan, J D, Bitran, P C, Hoffman, A G, Little, M K, Ferguson, R, Weichselbaum, H M, Golomb
Publikováno v:
Cancer. 59(12)
Seventy-eight patients with modified Stage II or Stage IIIM0 adenocarcinoma of the lung were evaluated retrospectively with regard to the impact of prophylactic cranial irradiation (PCI) (30 Gy in 15 fractions) in preventing central nervous system (C
Publikováno v:
Blood. 65(3)
Nine patients with progressive hairy cell leukemia were treated with subcutaneous injections of recombinant alpha 2 interferon (2 to 10 X 10(6) U/m2) three times weekly. Eight patients completed at least eight weeks of treatment and were evaluable; o
Autor:
R H, Jacobs
Publikováno v:
Journal of geriatric psychiatry. 11(1)
Publikováno v:
Cancer treatment reports. 71(3)
Fourteen previously untreated patients with metastatic small cell lung carcinoma (SCLC) were treated with carboplatin, 400 mg/m2, given as a 1-hour infusion every 28 days. Eleven patients had a partial response to therapy [response rate, 79% (95% con
Autor:
R H, Jacobs, B, Hess
Publikováno v:
Long term care and health services administration quarterly. 2(3)